HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerhard Wiche Selected Research

Plectin

3/2022Correction to: Plectin ensures intestinal epithelial integrity and protects colon against colitis.
2/2022Correction: Plectin ensures intestinal epithelial integrity and protects colon against colitis.
1/2021Plectin ensures intestinal epithelial integrity and protects colon against colitis.
1/2021Identifying Plectin Isoform Functions through Animal Models.
1/2018Plectin controls biliary tree architecture and stability in cholestasis.
1/2017An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
12/2015The cytolinker plectin regulates nuclear mechanotransduction in keratinocytes.
8/2015Plectin isoform P1b and P1d deficiencies differentially affect mitochondrial morphology and function in skeletal muscle.
6/2015Keratins Stabilize Hemidesmosomes through Regulation of β4-Integrin Turnover.
6/2015Mutation in exon 1a of PLEC, leading to disruption of plectin isoform 1a, causes autosomal-recessive skin-only epidermolysis bullosa simplex.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerhard Wiche Research Topics

Disease

11Muscular Dystrophies (Muscular Dystrophy)
08/2015 - 06/2002
8Epidermolysa bullosa simplex and limb girdle muscular dystrophy
01/2021 - 06/2002
8Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
12/2015 - 01/2002
4Neoplasms (Cancer)
01/2017 - 11/2010
3Colitis
03/2022 - 01/2021
2Wounds and Injuries (Trauma)
06/2015 - 08/2006
2Epidermolysis Bullosa
06/2015 - 03/2012
2Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 03/2006
2Myofibrillar Myopathy
03/2014 - 01/2013
1Ulcerative Colitis
01/2021
1Rupture
01/2018
1Infarction (Infarctions)
01/2018
1Cholestasis
01/2018
1Cardiomyopathies (Cardiomyopathy)
06/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2014
1Neoplasm Metastasis (Metastasis)
04/2014
1Pathological Protein Aggregation
03/2014
1Pancreatitis
01/2014
1Adenocarcinoma
11/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2013
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2013
1Sarcoma (Soft Tissue Sarcoma)
03/2012
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
12/2011
1Dystonia musculorum deformans type 1
10/2008
1Skin Diseases (Skin Disease)
03/2008
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
03/2007
1Alexander Disease (Alexander's Disease)
03/2006
1Nervous System Diseases (Neurological Disorders)
03/2006
1Glioma (Gliomas)
11/2005
1Inborn Genetic Diseases (Disease, Hereditary)
02/2003
1Mitochondrial Diseases (Mitochondrial Disease)
06/2002
1Autosomal Recessive Epidermolysis Bullosa Simplex
06/2002

Drug/Important Bio-Agent (IBA)

32PlectinIBA
03/2022 - 01/2002
13Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2004
5DesminIBA
03/2014 - 06/2002
4Keratins (Keratin)IBA
01/2018 - 11/2010
4Protein Isoforms (Isoforms)IBA
06/2015 - 02/2003
2epiplakinIBA
06/2015 - 01/2014
2VimentinIBA
04/2014 - 10/2008
1Laminin (Merosin)IBA
07/2014
1IntegrinsIBA
07/2014
1Actins (F Actin)IBA
04/2014
1CeruletideIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
11/2013
1Glucose (Dextrose)FDA LinkGeneric
06/2013
1Protein AggregatesIBA
01/2013
1RNA Precursors (Precursor, mRNA)IBA
03/2012
1Carrier Proteins (Binding Protein)IBA
11/2010
1Leucine (L-Leucine)FDA Link
03/2008
1Peptides (Polypeptides)IBA
03/2008
1Nonsense Codon (Nonsense Mutation)IBA
03/2008
1Codon (Codons)IBA
03/2008
1Protein Kinases (Protein Kinase)IBA
08/2006
1Mitogen-Activated Protein Kinase 3IBA
08/2006
1Glial Fibrillary Acidic ProteinIBA
03/2006
1RNA (Ribonucleic Acid)IBA
11/2005
1AntibodiesIBA
01/2002

Therapy/Procedure

1Oral Administration
01/2017
1Therapeutics
02/2003